Reviva Pharmaceuticals Holdings, Inc. (RVPH)

NASDAQ: RVPH · Real-Time Price · USD

0.2780

-0.0433 (-13.48%)

Dec 24, 2025, 4:00 PM EST - Market closed

RVPH Employees

Reviva Pharmaceuticals Holdings had 14 employees as of December 31, 2024. The number of employees decreased by 1 or -6.67% compared to the previous year.

Employees

14

Change (1Y)

-1

Growth (1Y)

-6.67%

Revenue / Employee

n/a

Profits / Employee

-$1,625,479

Market Cap

31.99M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	14	-1	-6.67%
Dec 31, 2023	15	5	50.00%
Dec 31, 2022	10	5	100.00%
Dec 31, 2021	5	0	-
Dec 31, 2020	5	1	25.00%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

RVPH News

1 day ago - FDA Asks Reviva Pharmaceuticals To Conduct Additional Phase 3 Study For Its Schizophrenia Drug - Benzinga
1 day ago - Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia - GlobeNewsWire
5 weeks ago - Reviva Reports Third Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
2 months ago - Reviva to Present Negative Symptom Data for Brilaroxazine in Schizophrenia from the Phase 3 RECOVER Double-Blind and Open-Label Extension Trials at the CNS Summit 2025 - GlobeNewsWire
2 months ago - Reviva to Participate in Key Opinion Leader Webinar Hosted by Alliance Global Partners - GlobeNewsWire
3 months ago - Top 3 Health Care Stocks That May Explode In September - Benzinga
3 months ago - Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $9 Million Public Offering - GlobeNewsWire
3 months ago - Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering - GlobeNewsWire